DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



Optimal Pharmacological Therapy In Implantable Defibrillator Patients (OPTIC)

Information source: Connolly, Stuart, M.D.
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Ventricular Tachycardia

Intervention: amiodarone beta blocker sotalol (Drug)

Phase: Phase 4

Status: Completed

Sponsored by: Connolly, Stuart, M.D.

Official(s) and/or principal investigator(s):
Stuart Connolly, Principal Investigator, Affiliation: McMaster University

Summary

This is an open parallel design randomized trial of amiodarone plus a beta blocker vs a beta blocker alone vs sotalol for the prevention of ICD shocks in patients receiving an ICD for spontaneous or inducible ventricular tachycardia or fibrillation

Clinical Details

Study design: Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention

Primary outcome: ICD shock for any cause

Eligibility

Minimum age: 18 Years. Maximum age: N/A. Gender(s): Both.

Criteria:

Inclusion Criteria: spontaneous or inducible ventricular tachycardia or fibrillation -

Exclusion Criteria:

-

Locations and Contacts

McMaster University, Hamilton, Ontario, Canada
Additional Information

Starting date: January 2001
Last updated: July 26, 2006

Page last updated: August 23, 2015

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017